nifedipine has been researched along with Dental Plaque in 14 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Dental Plaque: A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study showed that neither GCF nor plasma nifedipine levels appeared to be a risk factor for nifedipine-induced gingival overgrowth." | 7.74 | Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth. ( Bozkurt, A; Cağlayan, F; Dinçel, A; Güncü, GN; Karabulut, E; Ozmen, S, 2007) |
| "The purpose of this study was to examine the composition of subgingival plaque of 140 periodontal lesions in 35 patients with cardiovascular disorders who were administered nifedipine and manifested nifedipine-induced gingival overgrowth (GO)." | 7.70 | Subgingival microflora associated with nifedipine-induced gingival overgrowth. ( Andronikaki, A; Kamma, JJ; Mitsis, F; Nakou, M, 1998) |
| "The present study showed that neither GCF nor plasma nifedipine levels appeared to be a risk factor for nifedipine-induced gingival overgrowth." | 3.74 | Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth. ( Bozkurt, A; Cağlayan, F; Dinçel, A; Güncü, GN; Karabulut, E; Ozmen, S, 2007) |
| "Severe gingival hyperplasia (GH) is one of the most frequent side-effects associated with the prescription of Cyclosporine-A (CsA)." | 3.71 | Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. ( Baboolal, K; Newcombe, RG; Subramanian, N; Thomas, DW, 2001) |
| "The purpose of this study was to examine the composition of subgingival plaque of 140 periodontal lesions in 35 patients with cardiovascular disorders who were administered nifedipine and manifested nifedipine-induced gingival overgrowth (GO)." | 3.70 | Subgingival microflora associated with nifedipine-induced gingival overgrowth. ( Andronikaki, A; Kamma, JJ; Mitsis, F; Nakou, M, 1998) |
| " Gingival overgrowth was present in 41% of liver recipients receiving cyclosporin with or without nifedipine, but not in the majority receiving tacrolimus at the final examination." | 3.70 | Oral health in children undergoing liver transplantation. ( Beighton, D; O'Brien, G; Roberts, GJ; Sheehy, EC, 2000) |
| "Gingival overgrowth was noticed in 29% of the patients." | 1.30 | The clinical effects of nifedipine on periodontal status. ( Caglayan, F; Caglayan, G; Eratalay, K; Tavassoli, S; Yamalik, N, 1998) |
| " Duration of treatment, dosage of drugs per kg body weight and serum cyclosporin levels were recorded." | 1.30 | Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. ( Ashley, FP; Koffman, CG; Morel, A; Ogg, CS; Rigden, SP; Smith, D; Wilson, RF, 1998) |
| "The nifedipine-treated rats (experimental group) were fed a caries-inducing diet containing nifedipine either with or without infection, while the nifedipine-untreated rats (control group) were fed the same diet, similarly with or without the infection." | 1.29 | Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. ( Ishida, H; Kato, K; Loyola-Rodriguez, JP; Morisaki, I; Nagata, T, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (78.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Güncü, GN | 1 |
| Cağlayan, F | 2 |
| Dinçel, A | 1 |
| Bozkurt, A | 1 |
| Ozmen, S | 1 |
| Karabulut, E | 1 |
| Rossmann, JA | 1 |
| Ingles, E | 1 |
| Brown, RS | 2 |
| Morisaki, I | 2 |
| Kato, K | 1 |
| Loyola-Rodriguez, JP | 1 |
| Nagata, T | 2 |
| Ishida, H | 2 |
| Nishikawa, S | 1 |
| Oka, T | 1 |
| Ciantar, M | 1 |
| Tavassoli, S | 1 |
| Yamalik, N | 1 |
| Caglayan, G | 1 |
| Eratalay, K | 1 |
| Nakou, M | 1 |
| Kamma, JJ | 1 |
| Andronikaki, A | 1 |
| Mitsis, F | 1 |
| Wilson, RF | 1 |
| Morel, A | 1 |
| Smith, D | 1 |
| Koffman, CG | 1 |
| Ogg, CS | 1 |
| Rigden, SP | 1 |
| Ashley, FP | 1 |
| Sheehy, EC | 1 |
| Roberts, GJ | 1 |
| Beighton, D | 1 |
| O'Brien, G | 1 |
| Thomas, DW | 1 |
| Baboolal, K | 1 |
| Subramanian, N | 1 |
| Newcombe, RG | 1 |
| Pan, WL | 1 |
| Chan, CP | 1 |
| Huang, CC | 1 |
| Lai, MK | 1 |
| Romanos, GE | 1 |
| Schröter-Kermani, C | 1 |
| Hinz, N | 1 |
| Bernimoulin, JP | 1 |
| Beaver, WT | 1 |
| Bottomley, WK | 1 |
| Hancock, RH | 1 |
| Swan, RH | 1 |
3 reviews available for nifedipine and Dental Plaque
| Article | Year |
|---|---|
Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model.
Topics: Age Factors; Animals; Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Plaque; Diseas | 1996 |
Nifedipine-induced gingival overgrowth: remission following non-surgical therapy.
Topics: Calcium Channel Blockers; Combined Modality Therapy; Dental Plaque; Denture, Partial, Removable; Gin | 1996 |
On the mechanism of drug-induced gingival hyperplasia.
Topics: Dental Plaque; Diltiazem; Epidermal Growth Factor; Fibroblasts; Folic Acid; Gingival Hyperplasia; Gl | 1991 |
11 other studies available for nifedipine and Dental Plaque
| Article | Year |
|---|---|
Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth.
Topics: Adult; Aged; Dental Plaque; Epidemiologic Methods; Female; Gingival Crevicular Fluid; Gingival Overg | 2007 |
Multimodal treatment of drug-induced gingival hyperplasia in a kidney transplant patient.
Topics: Adult; Chlorhexidine; Cyclosporine; Dental Care for Chronically Ill; Dental Plaque; Drug Interaction | 1994 |
Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats.
Topics: Analysis of Variance; Animals; Dental Plaque; Dental Plaque Index; Disease Models, Animal; Gingival | 1993 |
The clinical effects of nifedipine on periodontal status.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Angina Pectoris; Calcium Channel Blockers; Dental Pl | 1998 |
Subgingival microflora associated with nifedipine-induced gingival overgrowth.
Topics: Adult; Age Factors; Aged; Bacteroidaceae; Bacteroides; Calcium Channel Blockers; Campylobacter; Capn | 1998 |
Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Azathioprine; Body We | 1998 |
Oral health in children undergoing liver transplantation.
Topics: Adolescent; Case-Control Studies; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; De | 2000 |
Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcium Channel Blockers; Child; Child, Preschool; Creatinine | 2001 |
Cyclosporine-induced gingival overgrowth.
Topics: Cyclosporine; Dental Plaque; Gingival Hypertrophy; Humans; Immunosuppressive Agents; Kidney Transpla | 1992 |
Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia.
Topics: Actin Cytoskeleton; Adult; Connective Tissue; Connective Tissue Cells; Cyclosporine; Dental Plaque; | 1992 |
Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque.
Topics: Dental Calculus; Dental Plaque; Dental Scaling; Gingival Hyperplasia; Humans; Male; Middle Aged; Nif | 1992 |